Summary of Use during Lactation

No information is available on the use of lemborexant during breastfeeding. Because it is about 94% bound to plasma proteins, amounts in milk are likely to be small. If lemborexant is required by the mother, it is not a reason to discontinue breastfeeding. However, until more data become available, an alternate drug may be preferred, especially while nursing a newborn or preterm infant. Monitor the infant for sedation, poor feeding and poor weight gain.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Zaleplon, Zolpidem

Substance Name

Lemborexant

CAS Registry Number

1369764-02-2

Drug Class

Breast Feeding

Lactation

Milk, Human

Hypnotics and Sedatives

Orexin Receptor Antagonists

Sleep Aids, Pharmaceutical